Clinical Trials
28 trialsOcular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Pfizer
OPTICS
DL Analytics
Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery
Stanford University
Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer.
Karolinska Institutet
RObese
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Carboprost (Hemabate) for Fibroid Resection
Northwestern University
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
The First Affiliated Hospital with Nanjing Medical University
Clinical Investigation of the da Vinci Surgical System
Intuitive Surgical
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Advaxis, Inc.
ERAS
Shandong University
BOOST
AGO Study Group
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer
Catalysis SL
AVANIRA3
Jiangsu Cancer Institute & Hospital
ANLOLA
Jiangsu Cancer Institute & Hospital
IOTA-MRI
KU Leuven
ERASGYNBS001
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers
Belgian Gynaecological Oncology Group
SALPINGOVA
University Hospital, Tours
ABVDATROUF
Second Affiliated Hospital of Wenzhou Medical University
Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia
Genexine, Inc.
A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients
Novartis
Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma
AGO Study Group
Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)
Merck Sharp & Dohme LLC
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Novartis
OB-ALFX
Catholic University of the Sacred Heart
A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)
Tesaro, Inc.
A Study of Trabectedin in Patients With Advanced Ovarian Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
M.D. Anderson Cancer Center